Guest guest Posted February 28, 2010 Report Share Posted February 28, 2010 Measurements of DNA content and proPSA levels at diagnosis are able to predict unfavorable biopsy conversion-free survival and may be useful to stratify an EM cohort that meets the Epstein criteria for T1c disease....Click on the below link for the full story:<http://www.urotoday.com/3341/browse_categories/beyond_the_abstract/beyond_the_abstract__proprostatespecific_antigen_measurements_in_serum_and_tissue_are_associated_with_treatment_necessity_among_men_enrolled_in_expectant_management_for_prostate_cancer_by_robert_w_veltri_phd0224>Non-doctors are welcome to browse UroToday.com but you'll be requested to register, which you can safely do, since this professional medical site never sends spam! Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.